NBPF14 Activators would be a theoretical class of chemical entities designed to selectively bind to and enhance the activity of the NBPF14 protein, which is presumed to be part of the Neuroblastoma Breakpoint Family (NBPF). Given the NBPF proteins' involvement in complex genomic and cellular processes, activators of NBPF14 would be developed to facilitate the exploration of the protein's function. The initial step in developing such activators would be a comprehensive investigation into the structure and function of NBPF14 to identify domains vital for its activity. Research tools such as X-ray crystallography, cryo-electron microscopy, or NMR spectroscopy would be employed to elucidate the three-dimensional structure of NBPF14, thus uncovering potential binding sites for activators. Furthermore, understanding the protein's structure-function relationship is crucial, as it would guide the identification of allosteric sites that, when targeted by activators, could modulate NBPF14 activity without directly interfering with its active site.
Following the structural characterization of NBPF14, the design of activator molecules would typically involve a combination of computational modeling and high-throughput chemical screening. Computational approaches, such as molecular docking and dynamics simulations, would be used to predict how small molecules might interact with the protein and influence its activity. These in silico techniques help streamline the discovery process by prioritizing compounds with the best theoretical interaction profiles for subsequent synthesis and testing. Synthetic chemistry would then be employed to produce the candidate molecules, which would be evaluated for their ability to activate NBPF14 in a series of biochemical assays. These assays would provide quantitative data on the binding affinity, specificity, and potency of the activators, informing further rounds of compound optimization. Through iterative design, synthesis, and testing, a refined class of NBPF14 Activators could be produced. Such compounds would provide valuable research tools, enabling scientists to probe the biological roles of NBPF14 and to further understand the contributions of the NBPF family to cellular and genetic networks.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is an HDAC inhibitor that can change chromatin structure and potentially increase NBPF14 expression through epigenetic modulation. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
As a DNA methyltransferase inhibitor, it could lead to demethylation and activation of gene expression, potentially affecting NBPF14. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
A polyphenol that may modulate epigenetic marks and has been shown to affect gene expression, which could hypothetically include NBPF14. | ||||||
Dimethyl Sulfoxide (DMSO) | 67-68-5 | sc-202581 sc-202581A sc-202581B | 100 ml 500 ml 4 L | $31.00 $117.00 $918.00 | 136 | |
Often used as a solvent, DMSO can also influence cell differentiation and gene expression, which might affect NBPF14 expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid and its derivatives influence gene expression during development; such compounds might affect NBPF14 expression in a neurodevelopmental context. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
As a potent estrogen, beta-estradiol can activate estrogen receptors and potentially influence the expression of genes like NBPF14. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
A glucocorticoid that can regulate gene expression through glucocorticoid response elements; may affect NBPF14 expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
An antitumor antibiotic known to bind DNA and affect transcription, which might hypothetically influence NBPF14 expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Histone deacetylase inhibitor that can cause hyperacetylation of histones and could potentially enhance NBPF14 expression by altering chromatin accessibility. | ||||||
Enzastaurin | 170364-57-5 | sc-364488 sc-364488A sc-364488B | 10 mg 50 mg 200 mg | $259.00 $612.00 $1721.00 | 3 | |
A protein kinase C inhibitor which could modulate transcription factor activity and possibly influence NBPF14 expression. | ||||||